Document is current
Any future updates will be listed below
-
Authors
Roelands, Jessica https://orcid.org/0000-0003-3631-2041
Kuppen, Peter J. K. https://orcid.org/0000-0002-0294-3251
Ahmed, Eiman I.
Mall, Raghvendra https://orcid.org/0000-0003-1779-3150
Masoodi, Tariq https://orcid.org/0000-0002-9186-6349
Singh, Parul
Monaco, Gianni
Raynaud, Christophe
de Miranda, Noel F.C.C. https://orcid.org/0000-0001-6122-1024
Ferraro, Luigi
Carneiro-Lobo, Tatiana C.
Syed, Najeeb
Rawat, Arun
Awad, Amany
Decock, Julie https://orcid.org/0000-0002-4409-100X
Mifsud, William https://orcid.org/0000-0002-9805-6461
Miller, Lance D. https://orcid.org/0000-0003-3799-2528
Sherif, Shimaa
Mohamed, Mahmoud G.
Rinchai, Darawan https://orcid.org/0000-0001-8851-7730
Van den Eynde, Marc
Sayaman, Rosalyn W. https://orcid.org/0000-0003-1343-0619
Ziv, Elad https://orcid.org/0000-0002-2324-2884
Bertucci, Francois
Petkar, Mahir Abdulla https://orcid.org/0000-0002-0297-8075
Lorenz, Stephan
Mathew, Lisa Sara https://orcid.org/0000-0003-3177-2233
Wang, Kun https://orcid.org/0000-0001-9706-5174
Murugesan, Selvasankar
Chaussabel, Damien https://orcid.org/0000-0002-6131-7242
Vahrmeijer, Alexander L. https://orcid.org/0000-0001-9370-0011
Wang, Ena
Ceccarelli, Anna
Fakhro, Khalid A.
Zoppoli, Gabriele
Ballestrero, Alberto
Tollenaar, Rob A.E.M.
Marincola, Francesco M.
Galon, Jérôme https://orcid.org/0000-0001-9635-1339
Khodor, Souhaila Al https://orcid.org/0000-0003-4858-7130
Ceccarelli, Michele https://orcid.org/0000-0002-4702-6617
Hendrickx, Wouter https://orcid.org/0000-0002-7649-5092
Bedognetti, Davide https://orcid.org/0000-0002-5857-773X
-
Funding
Funding for this research was provided by:
Qatar National Research Fund (JSREP07-010-3-005, NPRP11S-0121-180351, NPRP11S-0121-180351, JSREP07-010-3-005)
Associazione Italiana per la Ricerca sul Cancro (IG 2018 - ID. 21846)
- License Information
-
More Information
Article History
Received: 29 December 2021
Accepted: 28 March 2023
First Online: 19 May 2023
Competing interests
: J.G. has patents associated with the immune prognostic biomarkers. J.G. is co-founder of HalioDx, a Veracyte company. Immunoscore a registered trademark owned by the National Institute of Health and Medical Research (Inserm) and licensed to HalioDx, a Veracyte company. D.B., G.Z. and M.C. are shareholder of Immunomica. The remaining authors declare no competing interests.
: The research includes local researchers from both the country where the samples were collected and the places where the samples were processed (The Netherlands and Qatar). Junior local scientists participated in the work and received training in the context of the research project, building up the capacity to conduct this type of research in Qatar. The research was approved by a Dutch and Qatari ethics board of the involved institutions. The research was undertaken to high standards in relation to biosafety and regulatory oversight. This research does not result in stigmatization, incrimination, discrimination or otherwise personal risk to participants. We have taken into account local and regional research relevant to this study.
